These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference. Enzi MB Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090 [No Abstract] [Full Text] [Related]
24. A defense of the learned intermediary doctrine. Goetz RB; Growdon KR Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470 [No Abstract] [Full Text] [Related]
25. Avoiding pregnancy: "A plan" versus plan B. Rudd G Ann Pharmacother; 2004 Sep; 38(9):1535-6. PubMed ID: 15280516 [No Abstract] [Full Text] [Related]
26. Tony Clement appointed as Canada's new health minister. Kondro W; Sibbald B CMAJ; 2006 Mar; 174(6):754. PubMed ID: 16534074 [No Abstract] [Full Text] [Related]
27. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
28. What do voters want? A clean bill of health. Colvin G Fortune; 2004 Feb; 149(4):70. PubMed ID: 14983667 [No Abstract] [Full Text] [Related]
29. Drug review "behind the curtain": a response to Professor Struve. O'Reilly JT Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971 [No Abstract] [Full Text] [Related]
30. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem. Teufel AT J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702 [No Abstract] [Full Text] [Related]
31. HIV drugs. New Congress could create hurdles for drug patents. AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17319014 [No Abstract] [Full Text] [Related]
32. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium. Garbutt BJ; Hofmann ME Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558 [No Abstract] [Full Text] [Related]
33. How Mr. Lupien views his new post as Canada's deputy minister of health. Geekie DA Can Med Assoc J; 1975 Aug; 113(3):239-41. PubMed ID: 1139523 [No Abstract] [Full Text] [Related]
34. Not worth the risk? Privacy advocates slam FDA's web-based safety program for high-risk drugs. Conn J Mod Healthc; 2007 Jul; 37(28):36-7. PubMed ID: 17821850 [No Abstract] [Full Text] [Related]
35. Health Care in the 2016 Election - A View through Voters' Polarized Lenses. Blendon RJ; Benson JM; Casey LS N Engl J Med; 2016 Oct; 375(17):e37. PubMed ID: 27783924 [No Abstract] [Full Text] [Related]
36. State of the ballot battles. Medical liability reform, funds to support children's hospitals, ER services and stem-cell research among measures in voters' hands. Taylor M Mod Healthc; 2004 Oct; 34(43):22-5. PubMed ID: 15554012 [No Abstract] [Full Text] [Related]
37. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
38. Indian company seeks US approval for generic AIDS drugs. Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779 [No Abstract] [Full Text] [Related]
39. Impact of US and Canadian precursor regulation on methamphetamine purity in the United States. Cunningham JK; Liu LM; Callaghan R Addiction; 2009 Mar; 104(3):441-53. PubMed ID: 19207353 [TBL] [Abstract][Full Text] [Related]
40. Forget US politicians' promises--Canada still cheap-drug mecca. Korcok M CMAJ; 2002 Oct; 167(9):1044. PubMed ID: 12403755 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]